Today's Daily Dose brings you news about Abeaona's leadership and Board transitions, GENFIT's deal with LabCorp., FDA hold on Inovio's planned Phase 2/3 Covid-19 vaccine trial, the new CEO of Merck KGaA, and label expansion of Pfizer's blockbuster drug Xeljanz.
from RTT - Biotech https://ift.tt/3idLj8s
via IFTTT
No comments:
Post a Comment